Democrat State Representative Credits Hydroxychloroquine, Trump With Saving Her Life After Coronavirus
A member of the Michigan legislature who was diagnosed with Chinese coronavirus is crediting hydroxychloroquine and President Trump’s suggestion of the drug’s effectiveness with saving her life.
Rep. Karen Whitsett of Detroit learned that she had tested positive for coronavirus on Monday, but began taking the drug last month when experiencing severe symptoms of the disease. She had sought treatment with her husband on March 18th after falling ill with symptoms associated with coronavirus.
After taking hydroxychloroquine, Whitsett recounted experiencing almost immediate relief from the debilitating symptoms of the virus. It took “less than two hours” after an initial dose that the most severe symptoms of the disease, such as swollen lymph nodes and difficulty breathing, were abated.
The use of hydroxychloroquine has proven a topic of contention, with mainstream media journalists hectoring Trump for suggesting that the drug could prove useful in treating the disease even after large numbers of doctors report preliminary success in using it to treat coronavirus. The drug isn’t yet certified by the FDA as a verifiable drug in treating the disease, but by all indications, it has proven to be a medical game-changer in numerous cases of the disease, including Whitsett’s case.
Whitsett, a Detroit Democrat, has spoken candidly in support of Trump’s suggestion of use of the drug. “It has a lot to do with the president … bringing it up. He is the only person who has the power to make it a priority.”
The President went on to congratulate Whitsett for turning the corner in her struggle against coronavirus in a Monday tweet.
You don’t have to be a doctor to recognize that hydroxychloroquine has proven to be demonstrably beneficial in numerous documented cases of coronavirus documentation. By all means, further research and clinical trials are required, but there are many potentially lethal cases of the disease in which red tape could very plausibly prove more dangerous than trial use of the drug.